Lyell Immunopharma Inc

Research Lyell Immunopharma Inc (LYEL) on Bullrun: market cap USD 297.44M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLYEL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 297.44M
• Financial periodFY2025
• RevenueUSD 36.00K
• Revenue growth-41.0%
• Net income-USD 274.45M
• Free cash flow-USD 150.80M

Valuation Snapshot

latest market cap is USD 297.44M.

About Lyell Immunopharma Inc

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Frequently asked questions

What is Lyell Immunopharma Inc's market cap?

Lyell Immunopharma Inc's market capitalization is USD 297.44M.

What does Lyell Immunopharma Inc do?

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.